These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374 [TBL] [Abstract][Full Text] [Related]
26. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608 [TBL] [Abstract][Full Text] [Related]
27. Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Fujiki N; Yoshida Y; Zhang S; Sakurai T; Yanagisawa M; Nishino S Peptides; 2006 Sep; 27(9):2326-31. PubMed ID: 16626839 [TBL] [Abstract][Full Text] [Related]
28. Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Overeem S; Geleijns K; Garssen MP; Jacobs BC; van Doorn PA; Lammers GJ Neurosci Lett; 2003 Apr; 341(1):13-6. PubMed ID: 12676332 [TBL] [Abstract][Full Text] [Related]
29. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Kok SW; Roelfsema F; Overeem S; Lammers GJ; Frölich M; Meinders AE; Pijl H Am J Physiol Endocrinol Metab; 2005 May; 288(5):E892-9. PubMed ID: 15625087 [TBL] [Abstract][Full Text] [Related]
30. Voxel-based morphometry in hypocretin-deficient narcolepsy. Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731 [TBL] [Abstract][Full Text] [Related]
31. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137 [TBL] [Abstract][Full Text] [Related]
32. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990 [TBL] [Abstract][Full Text] [Related]
33. Sleep and cardiovascular phenotype in middle-aged hypocretin-deficient narcoleptic mice. Silvani A; Bastianini S; Berteotti C; Cenacchi G; Leone O; Lo Martire V; Papa V; Zoccoli G J Sleep Res; 2014 Feb; 23(1):98-106. PubMed ID: 24033681 [TBL] [Abstract][Full Text] [Related]
34. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044 [TBL] [Abstract][Full Text] [Related]
35. IGFBP3 colocalizes with and regulates hypocretin (orexin). Honda M; Eriksson KS; Zhang S; Tanaka S; Lin L; Salehi A; Hesla PE; Maehlen J; Gaus SE; Yanagisawa M; Sakurai T; Taheri S; Tsuchiya K; Honda Y; Mignot E PLoS One; 2009; 4(1):e4254. PubMed ID: 19158946 [TBL] [Abstract][Full Text] [Related]
36. Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy. Fujiki N; Nishino S CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):45-62. PubMed ID: 17305553 [TBL] [Abstract][Full Text] [Related]
37. CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency? Arnulf I; Lin L; Zhang J; Russell IJ; Ripley B; Einen M; Nevsimalova S; Bassetti C; Bourgin P; Nishino S; Mignot E Sleep; 2006 Aug; 29(8):1017-24. PubMed ID: 16944669 [TBL] [Abstract][Full Text] [Related]
38. Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins. Schwimmer H; Stauss HM; Abboud F; Nishino S; Mignot E; Zeitzer JM J Appl Physiol (1985); 2010 Oct; 109(4):1053-63. PubMed ID: 20705949 [TBL] [Abstract][Full Text] [Related]
39. Narcolepsy in a hypocretin/orexin-deficient chihuahua. Tonokura M; Fujita K; Morozumi M; Yoshida Y; Kanbayashi T; Nishino S Vet Rec; 2003 Jun; 152(25):776-9. PubMed ID: 12846289 [TBL] [Abstract][Full Text] [Related]
40. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]